Form D · Biotechnology
NASCENT BIOLOGICS INC
San Diego, CA · CIK 0001446997
Offering snapshot reported Jun 28, 2011 · SEC filing
- Reported sold
- $30K Offering amount: $70K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 17, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 28, 2011 | Initial | $30,000 | No comparison | 1 | SEC filing |
| Sep 29, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-161920
Source: Form D, filed Jun 28, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Onur Boyman | Director |
| Mark Glassy | Director, Executive |
| Jonathan Sprent | Director |
| Charles Surh | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10246 Parkdale Avenue
San Diego, CA, 92126
San Diego, CA, 92126